Celecoxib CV risk increased at higher dosages

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2008年 / 1197卷 / 1期
关键词：
Public Health; Adverse Event; Placebo; Cardiovascular Risk; Randomise Control Trial;
D O I：
10.2165/00128415-200811970-00007
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [41] PATIENTS WITH ESTABLISHED CV DISEASE HAD HIGHER PREVALENCE OF SEVERAL RISK CV INDICATORS, WHEN COMPARED TO HIGH CV RISK POPULATION WITHOUT PREVIOUS EVENT
    Pires, J.
    Pinto, S.
    Teixeira, M.
    Ferreira, F.
    Ribau, V.
    Neves, C.
    Mesquita Bastos, J.
    JOURNAL OF HYPERTENSION, 2017, 35 : E182 - E183
  • [42] Increased risk of AEs with higher ritonavir concentrations
    Reactions Weekly, 1999, 781 (1) : 3 - 3
  • [43] CV knowledge and risk perceptions among underserved individuals at increased risk for cardiovascular disease
    Homko, C
    Zamora, L
    Shirk, G
    Santamore, WP
    Cross, RC
    Kashem, A
    McCoyd, J
    McConnell, T
    Menapace, FJ
    Bove, AA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 263A - 263A
  • [44] No increased risk of CV events with stimulants in under-18s
    Reactions Weekly, 2012, 1412 (1) : 4 - 4
  • [45] High normal blood pressure value, is the patient at increased CV risk?
    Costantino Mancusi
    Christian Basile
    Ilaria Fucile
    Journal of Human Hypertension, 2022, 36 : 589 - 590
  • [46] GnRH agonists: risk of major CV events incurring increased costs
    Reactions Weekly, 2020, 1833 (1) : 6 - 6
  • [47] Celecoxib and Cardiovascular Risk
    Kayyali, Andrea
    AMERICAN JOURNAL OF NURSING, 2009, 109 (03) : 29 - 29
  • [48] uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer
    Qin, Wenyi
    Zhu, Weizhu
    Hewett, John E.
    Rottinghaus, George
    Chen, Yin-Chieh
    Flynn, John T.
    Kliethermes, Beth
    Mannello, Ferdinando
    Sauter, Edward R.
    BMC CANCER, 2008, 8 (1)
  • [49] Celecoxib and cardiovascular risk
    Reactions Weekly, 2008, 1205 (1) : 4 - 4
  • [50] Warfarin + celecoxib/rofecoxib: increased INR
    Reactions Weekly, 2003, 964 (1) : 3 - 3
12345